The global fluoroscopy systems market size is expected to reach USD 2.37 billion by 2030, expanding at a CAGR of 2.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The unprecedented growth is believed to be a consequence of rising patient preference for minimally invasive surgeries. These devices facilitate early diagnosis and reduce treatment duration in majority of surgical procedures.
The growing demand is also a consequence of improved cost-efficiency, safety, efficacy, rapid recovery, and reduced hospital stay. These factors anticipated to fuel the demand for fluoroscopy equipment over the forecast period. Other advantages include fewer incision wounds and postsurgical complications that lead to higher patient satisfaction.
The market is also driven by technological advancements such as incorporation of radiation dose monitoring tools for optimized radiation in fluoroscopy equipment. Other advancements include robotically controlled C-arms, integrated navigation tools, and image guidance software. These advancements have led to enhanced image guidance during interventional, ablation, and biopsy procedures as well as improved optimization of working procedures.
Request a free sample copy or view report summary: Fluoroscopy Systems Market Report
C-arms segment is predicted to witness exponential growth owing to high cost-efficiency and wide applicability in different fields such as traumatology, orthopedics, vascular surgery for intraoperative imaging, and others.
Cardiovascular emerged as the largest application segment in 2023 as a consequence of high prevalence of cardiovascular diseases, raising the clinical urgency for adoption of fluoroscopy equipment.
Hospitals held the largest share in end-use segment due to high patient volume, consistent readmissions, and easy availability of high-end equipment.
North America accounted for the largest share, which can be attributed to the extensive R&D activities that are likely to provide platform for growth through consistent approvals of new product.
The fluoroscopy equipment market in Asia Pacific is projected to witness substantial growth over the next decade, due to growing awareness pertaining to availability and benefits of these devices, further triggering significant penetration.
GE Healthcare, Philips Healthcare, and Siemens Healthineers together accounted for a dominant share in the global fluoroscopy equipment market in 2023.
The key companies are aggressively undertaking collaborative strategies, new and advanced product development activities, and mergers & acquisitions leading to significant growth.
In July 2023, Canon Medical Systems launched a multipurpose fluoroscopic table with new functions, Zexira i9 digital X-ray RF system. It is a digital X-ray RF system which is equipped with all the essential features to meet clinical demands.
Grand View Research has segmented the global fluoroscopy systems market based on product, application, end use, and region:
Fluoroscopy Systems Product Outlook (Revenue, USD Billion, 2018 - 2030)
Fluoroscopy Devices
C-arms
Fluoroscopy Systems Application Outlook (Revenue, USD Billion, 2018 - 2030)
Orthopedic
Cardiovascular
Pain Management & Trauma
Neurology
Gastrointestinal
Urology
General Surgery
Others
Fluoroscopy Systems End Use Outlook (Revenue, USD Billion, 2018 - 2030)
Hospitals & Specialty Clinics
Diagnostic Imaging centers
Others
Fluoroscopy Systems Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
KSA
UAE
South Africa
South Africa
List of Key Players in Fluoroscopy Systems Market
Canon Medical Systems Corporation.
Hitachi Medical Systems
Siemens Healthineers
Koninklijke Philips NV
GE HealthCare
Ziehm Imaging GmbH
Shimadzu
Orthoscan Inc.
Hologic Inc.
Carestream Health.
"The quality of research they have done for us has been excellent..."